Brief: Trevi Therapeutics Announces Pricing Of $55 Mln Public Offering
Sept 23 (Reuters) - Trevi Therapeutics Inc TRVI.O :
* ANNOUNCES PRICING OF $55 MILLION PUBLIC OFFERING
* SAYS PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 14.3
MILLION
SHARES OF STOCK AT PUBLIC OFFERING PRICE OF $1.93 PER SHARE
* PRICING PRE-FUNDED WARRANTS TO PURCHASE 14.3 MILLION
SHARES OF
STOCK AT $1.929 PER PRE-FUNDED WARRANT FOR PROCEEDS OF ABOUT $55
MILLION
Further company coverage: TRVI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million